Crevistar Tablets 2.5/5 mg (Nebivolol, Rosuvastatin)

Adult dose

This medication is administered for the convenience of patients who are taking nebivolol and rosuvastatin simultaneously, with a dosage of one tablet per day.

This medication should not be used by patients who are allergic to its specific components. It should also not be taken by patients with severely impaired liver function or ongoing liver disease. Administration is contraindicated for patients with bradycardia or problems with heart conduction. Patients with acute heart failure or cardiogenic shock, where heart function has sharply deteriorated, should also avoid this medication. It may pose risks for patients with very low blood pressure or severe peripheral circulation disorders. Patients with severely impaired kidney function, a history of bronchial asthma or bronchospasm should also avoid this medication. It is not administered to women who are pregnant, breastfeeding, or of childbearing age without adequate contraception. Patients with a history of muscle disease or a high risk of myopathy should avoid high doses of this medication. This drug is not to be used by patients with certain genetic metabolic disorders, like lactose intolerance. Chronic pulmonary disease, untreated heart failure, peripheral circulation disorders, thyroid abnormalities, and diabetic patients should use this medication cautiously. Should symptoms of myalgia or myopathy occur, notify healthcare providers immediately and discontinue medication if needed. This medication can affect liver and kidney function, making regular testing necessary. In elderly patients, it is crucial to start at a low dose and monitor their condition closely. This medication can interact with other drugs, so it is vital to inform healthcare providers about any medications being taken. Women who could become pregnant must employ proper contraceptive methods before taking this medication, and should stop taking it immediately if pregnant. Women who are breastfeeding are also advised not to take this medication. In case of overdose, seek medical attention immediately for appropriate treatment, which may include cardiac rhythm control or blood pressure maintenance therapy. Dizziness can occur while taking this medication, so caution is advised when driving or operating machinery. Keep this medication out of the reach of children and store it in its original container to prevent quality deterioration.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, sweating, paleness, severe allergic reactions, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucous membranes, severe cutaneous adverse reactions, difficulty breathing or shortness of breath, asthma attacks, respiratory issues accompanied by cough and fever, jaundice (yellowing of the skin or eyes), profound lethargy, liver abnormalities (jaundice), sudden and

Mild side effects

• Eye discharge
• upper abdominal discomfort
• gastritis
• gastroesophageal reflux disease
• chest pain
• nasopharyngitis
• influenza
• CK increase
• ALT increase
• AST increase

Store this medication in a tightly sealed container to protect it from air and moisture. It is important to maintain storage temperatures between 1 degree and 30 degrees Celsius.

Appearance

White to almost white round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle